Glimmer of hope: New ‘supercharged’ drug can protect nerve cells that lead to Alzheimer’s

LONDON: Scientists have developed a drug with potential to stop the breakdown of nerves and brain cells that may lead to Alzheimer’s, Parkinson’s and motor neuron disease.

Alzheimer’s disease is the most common type of dementia, which includes memory loss, confusion and problems with speech and understanding.

The drug is made up of “supercharged” vitamin A, which is found in vegetables like sprouts and carrots and miniature cabbages, the Daily Mail reported.

The study showed that vitamin A turns into a chemical called retinoic acid when broken down by the body, which is crucial for the development of the nervous system.

Glimmer of hope: New ‘supercharged’ drug can protect nerve cells that lead to Alzheimer’s
Higher levels of retinoic acid in the body could halt nerve damage and boost the number of nerve cells.

“We are moving forward with a new therapeutic which could be used to help people with Alzheimer’s disease,” Peter McCaffery, lead author and Professor from the Aberdeen University in Scotland, was quoted as saying.

“Our work is still at an early stage but we believe this is a positive development and the new drugs seem to protect nerve cells” he added.

With vitamin A making a difference, it is important to find ways of tackling neurological conditions, McCaffery said.

In addition, the drug may also benefit ALS or Lou Gehrig’s disease, which affects the muscles of the arms, legs, mouth and respiratory system.

  • Related Posts

    Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

    The National Pharmaceutical Pricing Authority (NPPA) has said that it is not mandatory for the oncology drug manufacturers who are revising the drug prices as per the recently announced Trade…

    Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

    Mankind Pharma shares jumped nearly 8% on Tuesday to an intraday high of Rs 2,500 on the NSE after the company reported a 38% year-on-year rise in Q2 profit after…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

    Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

    Yashoda Medicity: Baby takes a Giant Step in just One Year

    Yashoda Medicity: Baby takes a Giant Step in just One Year

    Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

    Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

    GLP-1 injections recalled across the US over sterility concerns

    GLP-1 injections recalled across the US over sterility concerns

    Govt allows third-party agencies to conduct departmental inspections

    Govt allows third-party agencies to conduct departmental inspections

    Fridge-free vaccines could reach more people, but there are still practical challenges in African settings

    Fridge-free vaccines could reach more people, but there are still practical challenges in African settings